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ABSTRACT
Objectives: The objective of the present work is to develop and characterize metronidazole microsphere-loaded bioadhesive vaginal gel to ensure 
longer residence time at the infection site, providing a favorable release profile for the drug.
Methods: Microsphere was prepared by solvent evaporation method in various ratios of metronidazole to poly-ε-caprolactone (PCL). Physicochemical 
evaluation of microspheres includes determination of solubility in simulated vaginal fluid, partition coefficient (n-octanol/citrate phosphate 
buffer pH 4.5), particle size distribution, entrapment efficiency, X-ray diffraction, and surface morphology by scanning electron microscopy (SEM). 
Drug excipient compatibility was established by Fourier transform infrared and differential scanning calorimetry studies. Bioadhesive gel was 
prepared using Carbopol 934P and HPMC K4M in various concentrations, and methyl paraben was used as a preservative. The pH was adjusted 
with triethanolamine which resulted in a translucent gel. The optimized metronidazole microsphere formulation was dispersed into the gel base. 
Microspheres in gel formulations were evaluated for pH, viscosity, spreadability, drug content, and gelling strength. Ex vivo mucoadhesive strength of 
the gel was determined on goat vaginal mucosa. In vitro drug release study was performed using cellophane membrane.
Results: The optimized batch of microsphere F4 (drug-polymer ratio 1:4) showed entrapment efficiency of 72.62±3.66%, solubility of 1.5 mg/ml, and 
partition coefficient of 0.12. Particle size of all the formulations was observed below 100 µm. Regular and spherical particles were observed in the 
SEM photomicrographs. The optimized gel formulation G5 (Carbopol and HPMC at 1: 0.25 ratio) showed viscosity of 7538 cps at 100 RPM, gel strength 
recorded as 35 secobds for a 1000.00 mg load, and spreadability of 4.6 g.cm/seconds. G5 showed 82.4% drug release at 10.0 hrs and mucoadhesive 
strength of 6.5±1.2 g.
Conclusion: The study results suggest that metronidazole-loaded PCL microsphere in mucoadhesive gel would provide a mean for sustained 
treatment of vaginal infections.
Keywords: Microsphere, Metronidazole, Bioadhesive vaginal gel.
INTRODUCTION
Vaginal drug delivery system is the system where the drug formulations 
are applied directly in the vaginal cavity for producing systemic and local 
action, and is considered important because the vaginal membrane has 
a dense network of blood vessels for effective drug absorption, large 
surface area, local effect, self-insertion, rich blood supply, and avoidance 
of the first-pass effect. The vaginal route is particularly used to treat 
vaginal infections, sexually transmitted diseases, or for contraception. 
Semisolid and solid dosage forms are preferred for this route and 
such dosage when tailored with bioadhesion properties prolongs the 
residence time in the vaginal cavity [1].
Metronidazole is a member of the imidazole class of antibacterial 
agents and is classified therapeutically as an antiprotozoal [2] and 
antibacterial agent [3]. Chemically, metronidazole is 2-methyl-5-
nitroimidazole-1-ethanol (Fig. 1). It acts against protozoa such 
as Trichomonas vaginalis, amebiasis, and giardiasis. It selectively 
acts against anaerobic bacteria. It disrupts DNA’s helical structure, 
thereby inhibiting bacterial nucleic acid synthesis. This eventually 
results in bacterial cell death [4]. Metronidazole is reported to have 
low bioavailability in vaginal route of administration (20-25%). It 
has low lipid solubility that probably contributes to its poor vaginal 
absorption. There are reports available on metronidazole-loaded 
microsphere system with better permeability to provide constant and 
prolonged therapeutic effect [5]. Microspheres are the small spherical 
particles that have the diameters in the micrometer range (typically 
1 μm to 1000 μm) [6]. Such prolonged acting system reduces the 
dosing frequency and improves the patient compliance [7]. Better 
drug utilization in the form of microspheres improves bioavailability 
and reduces the incidence or intensity of adverse effects. In addition, 
microsphere morphology allows a controllable variability in 
degradation and drug release [8].
Advancement of vaginal drug delivery was aided by mucoadhesive gel 
formulations. Kumar et al. (2014) reported in vitro-in vivo evaluation 
of microspheres-loaded topical gel delivery system of ketoconazole in 
male rats against Candida glabrata. They revealed that microspheres-
loaded gel of ketoconazole offers a convenient dosage form for 
achieving better release profiles and improved patient compliance. 
Dhaliwal et al. (2013) worked on preparation and characterization 
of bioadhesive vaginal gel of propranolol hydrochloride. They 
revealed that the films containing higher concentration of polymers 
released the drug slowly as compared to the formulations with lower 
concentration. The formulations maintained the sustained drug release 
for more than 54 hrs. Patel et al. (2013) worked on the formulation 
and evaluation of bioadhesive gel-incorporated amoxicillin trihydrate-
loaded microspheres for periodontal therapy. They found that the gel 
formulation, which consisted of drug-loaded gelatin microspheres, 
showed sustained release of amoxicillin trihydrate for more than 6 hrs. 
Yellanki et al. (2010) worked on the development of metronidazole 
intravaginal gel for the treatment of bacterial vaginosis. They concluded 
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that the bioadhesive intravaginal gel formulations are more effective as 
well as have better patient compliance than the existing conventional 
vaginal drug delivery systems. Tiwari (2010) worked on biodegradable 
microspheres for controlled delivery of metronidazole in the treatment 
of periodontal diseases. The study results suggested that the novel 
blend microparticles prepared from poly (L-lactic-co-glycolic acid) 
and poly-ε-caprolactone (PCL) are effective in controlled delivery 
of metronidazole to periodontal therapy. In the light of the literature 
reviewed, the present work proposed to develop metronidazole-loaded 
polycaprolactone microsphere and incorporation of the metronidazole 
microspheres in mucoadhesive gel for the treatment of vaginal 
infections. Carbopol 934 is widely used as mucoadhesive polymer in 
gel formulations and forms adhesive bond between a biological and 
a synthetic surface. Polycaprolactone is biodegradable polyester with 
low melting point of around 60°C and a glass transition temperature 
of about 60°C. Poly-ε-caprolactone (PCL) has been receiving increasing 
attention as matrix material for controlled release drug formulations. 
PCL and its derivatives, with a high permeability to many therapeutic 
drugs and lack of toxicity and non-irritability, is well suited for 
controlled drug delivery. However, the utilization of PCL is not explored 




Metronidazole, PCL, and carbopol 934P were purchased from Balaji 
Drugs, Mumbai, India. HPMC K4M, triethanolamine, and polyvinyl 
alcohol (PVA) were purchased from Merck Specialist Pvt. Ltd, Mumbai. 




Microspheres were prepared at room temperature by solvent 
evaporation technique using the quantity of drug and other excipients 
as given in the Table 1. PCL solution was prepared by dissolving PCL in 
dichloromethane (DCM). Under mechanical stirring with a three-blade 
propeller (REMI- RQ 122), the organic phase (10 mL) was poured into 
500 mL of water containing PVA (1%). Then, stirring was maintained 
for 1 hr at different rpm, leading to a total evaporation of the solvent 
(DCM). The microspheres were then recovered by filtration, washed 
three times with double-distilled water, and dried at room temperature 
for the next 24 hrs [9,10].
Formulation of mucoadhesive carbopol gel
Carbopol 934P was soaked overnight in minimum quantity of water 
and allowed to swell up. After 24 hrs, HPMCK4M was dispersed in 
various concentrations. Metronidazole microspheres were dispersed 
into the gel base. Methyl paraben was mixed as a preservative. The 
pH was adjusted with triethanolamine which resulted in a translucent 
gel.  The quantity of carbopol 934P, HPMCK4M methyl paraben and 
distilled water were used as given in the Table 2 [11].
Drug excipient compatibility study by Fourier transform infrared 
(FT-IR) and differential scanning calorimetry (DSC)
FT-IR study
The excipients were mixed individually with the pure drug in a ratio 
of 1:1 and the spectra were recorded using FT-IR Bruker, Alpha. The 
scanning range was 400-4000 cm−1 and the resolution was 2 cm−1 [12].
DSC study
The excipients were mixed individually with the pure drug in a 
ratio of 1:1, and the DSC study was performed. DSC of the bulk drug 
metronidazole was performed using DSC instrument (Perkin Almer, 
U.S.A.) for measurement of the heat loss or gain resulting from 
the physical or chemical changes within a sample as a function of 
temperature. About 6-7 mg of the individual component or drug 
excipient combinations were weighted in aluminum DSC pans, and 
hermetically sealed capsules were prepared with aluminum lids. An 
initial ramp was used to jump the temperature to 40°C and then a 




The particle size of microspheres was determined using an optical 
microscopy method. Approximately, 100 microspheres were counted 
using a calibrated microscope [14].
Scanning electron microscopy (SEM)
The shape and surface morphology of the microspheres was observed 
by SEM. The microsphere sample was thinly spread onto a metal stub 
and vacuum coated with a thin layer of gold in an argon atmosphere. 
The SEM photographs of the coated particles were obtained at 15 kV 
using an SEM, ZEISS, Germany [15].
Partition coefficient study
A separating funnel was thoroughly cleaned and dried into which 
20 ml of n-octanol and 20 ml of citrate phosphate buffer pH 4.5 were 
taken. About 10 mg of microsphere was added to it. Then, the funnel 
was shaken on a mechanical shaker for 24 hrs. The organic and 
aqueous fractions were separated. From the aqueous fraction, 0.5 ml 
of sample was withdrawn and diluted to 10 ml with distilled water. 
Then, the absorbance was measured at 309 nm using ultraviolet (UV) 
spectrophotometer (Shimadzu- Model No. UV 1800) [16].
Saturation solubility study of microsphere
The excess amount of drug was taken and added to 5 ml solvent (water, 
phosphate buffer pH 6.8, and citrate phosphate buffer pH 4.5) in a 
tightly capped glass vial. To mix properly, the sample was constantly 
agitated at 80 rpm at room temperature for 24 hrs in REMI rotary 
shaker. At the end of 24 hrs, the samples were centrifuged in a REMI 
centrifuge at 1000 rpm. The supernatant liquid was separated and from 
that 0.5 ml was transferred to 10 ml volumetric flask. The volume was 
made up to the mark with distilled water. Absorbance was determined 
at λmax 309 nm against citrate phosphate buffer as blank using UV 
spectrophotometer [17].
Fig. 1: Molecular formula of metronidazole





PVA (%) Time (hr) RPM
F1 1:1 1 1 1200
F2 1:0.5 1 1 1200
F3 0.5:1 1 1 1200
F4 1:0.75 1 1 1200
F5 0.75:1 1 1 1200
F6 1:0.25 1 1 1200
F7 0.25:1 1 1 1200
PVA: Polyvinyl alcohol
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Drug entrapment efficiency
Microspheres equivalent to 5 mg metronidazole were crushed using 
a glass mortar and pestle. Then, they were suspended in 25 ml of 
citrate phosphate buffer pH 4.5. After 24 hrs, the solution was filtered 
and 1 ml of the filtrate was diluted 10 times and analyzed for the 
drug content by UV-visible spectrophotometer at 309 nm [18]. 
The drug entrapment efficiency was calculated using the following 
formula:
Entrapment efficiency =  (actual drug content/theoretical drug 
content) ×100.
In vitro drug release study
The in vitro release of metronidazole microspheres was done in citrate 
phosphate buffer pH 4.5 for 7 hrs in USP-I Basket-type dissolution 
apparatus at a temperature of 37°0±0.5°C. The volume of the dissolution 
medium was 900 ml and agitated at 100 rpm throughout the study. 
Microspheres equivalent to 10 mg of drug were taken and they were 
transferred in the basket wrapping it with muslin cloth. The sample was 
taken in every half an hour for 7 hrs. To maintain the sink condition, the 
samples withdrawn were replaced with an equal volume of dissolution 
medium. After suitable dilution, samples were analyzed by UV-visible 
spectrophotometer at 309 nm [19].
Evaluation of microspheres-loaded gel
Determination of pH
Determination of pH was done by Indosati Digital pH meter (Systronics, 
335). pH meter was calibrated before use using standard buffer 
solution [11].
Viscosity
The viscosities of the formulated gels were determined by Brookfield 
viscometer using spindle no. 64 (DV-E Viscometer) [20].
Gel strength determination
A composition of 50 g of microspheres-loaded gel was taken in a 10 ml 
beaker. The weight of 1000 mg for measuring gel strength was allowed 
to penetrate into the gel. The gel strength, which means the viscosity of 
the gel, was determined by time (seconds), the weight took to sink 5 cm 
down through the prepared gel [21].
Spreadability
A sample of 0.5 g of each formulation was pressed between two 
slides (divided into squares of 5 mm sides) and left for about 
5 minutes where no more spreading was expected. Diameters of 
spreaded circles were measured in cm and were taken as comparative 
values for spreadability. The results obtained are average of three 
determinations [22].
Drug content
About 0.5 g of gel was dissolved in 25 mL citrate phosphate buffer at 
pH 4.5. It was then filtered after constant stirring and analyzed by UV 
spectrophotometer after suitable dilution at 309 nm [23].
Mucoadhesive strength
Mucoadhesive strength was determined using texture analyzer (TA.
XT EXPRESS). The mucoadhesive strength of the formulations was 
evaluated by measuring the force required to detach the formulation 
from a goat vaginal mucosa. Goat vaginal mucosa was obtained from 
a local slaughter shop; it was cleaned, subcutaneous fat and blood 
vessels were removed with a scalpel, washed thoroughly with double-
distilled water, and blotted dry by a tissue paper. Gel was heated to 
37°C so that it undergoes complete gelation and remains attached to 
the probe of the texture analyzer. Goat vaginal mucosa (about 2×2 cm2) 
was dipped in citrate phosphate buffer at pH 4.5. It was then placed in 
the plate attached to the texture analyzer; target force of 500.0 mg/
sec was applied. After keeping in contact for 10 s, the probe was then 
moved vertically upward at a constant speed of 5 mm s−1. Maximum 
detachment force (F) was obtained from the force-distance graph [24].
In vitro drug release study
In vitro release studies of metronidazole microspheres from the 
carbopol gel were carried out at 37°C using citrate phosphate buffer 
(pH 4.5) as the release medium. A glass tube of 10 mm diameter 
and 100 mm height was taken. One end of the tube was closed using 
cellophane membrane with the help of an adhesive tape, while the 
other end was kept open and used as drug reservoir compartment. Gel 
(1 g) containing metronidazole microspheres was accurately weighed 
and transferred to the glass tube in a vertical position through the open 
end. The gel was gently pushed down to the surface of the membrane. 
Citrate phosphate buffer (2 ml, pH 4.5) was added to the reservoir 
compartment to wet the gel. The glass tube was placed in a beaker 
containing 100 ml of citrate phosphate buffer (pH 4.5), in such a way 
that the membrane just touches the release medium. The receiving 
compartment was magnetically stirred (100 rpm, REMI, India) at 37°C. 
Samples (1 ml) were withdrawn from the receiving compartment at 
regular intervals, and the amount of metronidazole released from 
the gel was determined using a spectrophotometer at 309 nm. After 
each withdrawal of sample, equal quantity of citrate phosphate 
buffer was added to the receiving compartment to maintain the sink 
condition [25].
Antimicrobial efficacy study of metronidazole microspheres-
loaded bioadhesive carbopol vaginal gel
Antimicrobial efficacy studies were performed to ascertain the 
biological activity of the optimized vaginal gel batch G5 against Candida 
species (Candida albicans). The antifungal activity of the optimized 
formulation G5 was compared with the marketed formulation of MIZ 
cream. This was determined by agar diffusion test employing “cup 
and plate technique.” Marketed formulation of MIZ as a standard 
and optimized formulation was poured into cups bored into sterile 
Sabouraud dextrose agar medium previously seeded with Candida 
test organism. The Sabouraud dextrose agar media were prepared 
by suspending 40 g of dextrose, 10 g of peptone, and 15 g of agar in 
1000 ml of distilled water. The wells were filled with 0.16 g of marketed 
as well as optimized formulation with the help of a sterile syringe. The 
plates were kept at room temperature for 45 minutes to allow diffusion 
of gel in the inoculated medium. Thereafter, all the plates were kept at 
27°C and 37°C to check for fungal and bacterial growth, respectively, in 
the incubator for 24 hrs. The zone of inhibition was measured around 
each cup with Antibiotic zone scale (Himedia Laboratories Limited) and 
was compared with that of standard [26].
RESULTS AND DISCUSSION
Drug excipient compatibility study using FT-IR
FT-IR spectrum of drug and drug-polymer mixture is shown in 
Figs. 2 and 3, respectively. From the FT-IR spectra of drug and drug-
Table 2: Formulation of gel
Formulations Carbopol934p (% w/v) HPMC K4M (% w/v) Methyl paraben Distilled water
G1 1 - 0.02 q.s
G2 1 1 0.02 q.s
G3 1 0.75 0.02 q.s
G4 1 0.5 0.02 q.s
G5 1 0.25 0.02 q.s
G6 1 0.125 0.02 q.s
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polymer mixture, it was found that drug and polymer are compatible 
with each other.
Drug excipient compatibility study using DSC
For the preparation of a drug formulation, it is necessary to evaluate 
the interactions between the drug and the polymers. The DSC 
thermogram of pure metronidazole shows a sharp endothermic peak 
at 165.27°C which corresponds to its melting point. The thermogram of 
metronidazole with polycaprolactone shows sharp endothermic peak 
at 164.90°C, due to the presence of metronidazole. Thus, the thermal 
data shown in the Fig. 4, did not reveal any interaction between the 
drug and polymer.
Physico-chemical characteristics
Results show that the particle size of the prepared microspheres varied 
from 10.25 to 35.56 as shown in Table 3. The size of microspheres 
decreased with increase in polymer concentration.
The partition coefficients of the microspheres are listed in Table 3, 
and the microspheres showed better permeation than the drug 
metronidazole.
The average entrapment efficiency (%) of metronidazole microsphere 
formulations is shown in Table 3 and was found to be 58.54±1.18, 
63.32±2.1, 53.32±0.95, 72.62±3.66, 69.12±3.5, 56.40±1.1, and 
50.24±0.98 in the formulations F1, F2, F3, F4, F5, F6, and F7. The 
average entrapment efficiency of the formulations increased with 
increase in polymer concentration. The maximum entrapment 
efficiency (72.62±3.66) was observed in formulation F5. The change 
in drug entrapment may be due to poor aqueous solubility and high 
binding capacity of drug on polymer surface.
SEM
The microspheres prepared by solvent evaporation method have 
good spherical shape with smooth surface in its morphology, and the 
particles were distributed uniformly without forming any clump and it 
is shown in the Fig. 5. Particle sizes observed in SEM photomicrographs 
are in the same line as determined by optical microscopic method.
Release study of microspheres
In vitro release profile of metronidazole-loaded microspheres in citrate 
phosphate buffer pH 4.5 is shown in Fig. 6. Here, sustained release of 
drug was observed from the formulation in citrate phosphate buffer 
pH 4.5 for duration of 6 hrs. Here, we found that drug release is 
dependent on the concentration of the polymer that may be due to 
the hydration capability of polymer which on coming in contact with 
dissolution medium forms gelatinous mass that is retardant material 
for the drug to get diffused out. The cumulative percentage drug 
release from formulations F1, F2, F3, F4, F5,F6, and F7 is 68.9,73.6, 
69.5, 86.9, 75.8, 56.9, and 65.3. Thus, F4 formulation has higher drug 
release in citrate phosphate buffer pH 4.5 in comparison to the other 
formulations.
Evaluation of mucoadhesive gel
pH of the formulation was found in the range of 3.93-4.88, that is 
within the limit of vaginal semisolid specifications. The normal pH of 
Fig. 2: Fourier transform infrared spectra of metronidazole
Fig. 3: Fourier transform infrared spectra of physical mixture of drug and polymer (poly-ε-caprolactone)
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the vagina is in between 4 and 5. This indicates the nonirritancy of the 
formulation in the vaginal cavity. Viscosity increases with the increase 
in the concentration of the mucoadhesive polymer. Viscosity also 
decreases with the increase in the RPM. The value for viscosity of all the 
formulations is shown in Table 4. Spreadability of the formulated gels 
was found to be within the range of 3.5-5.5 g.cm/sec. As the viscosity 
of the formulation increases, the spreadability of the formulation 
decreases. The values of spreadability are shown in Table 5. Gel strength 
is calculated in time(s) and found within the range of 28-52 sec. The 
values of gel strength are shown in Table 5. Mucoadhesive strength was 
found within the range of 3.5-15.6 g. Drug content of all the formulation 
was found within the range of 52.30-70.02% as shown in Table 5.
In vitro diffusion study of gel
In vitro diffusion study of bioadhesive gel incorporated metronidazole-
loaded microspheres and compared with metronidazole microspheres. 
The cumulative release of metronidazole from microspheres and gel is 
shown in Fig. 7. Drug from the microspheres was released in a controlled 
manner. The release pattern was biphasic with an initial “burst” release 
of 28.4% of the loaded drug in the first 30 minutes. Thereafter, release 
was slow but steady, and by the end of the 7th hr, a maximum of 86.9% 
of the loaded drug was released (F4).
Metronidazole from the carbopol gel formulation is also shown in Fig. 7. 
The release pattern was biphasic with an initial “burst” release that was 
enhanced by the loading dose of metronidazole. By the end of the first 
30 minutes, 10.6% of the drug was released; subsequently, release was 
steady, and by the end of the 10th hr, a maximum of 82.4% of the drug 
was released.
The antimicrobial activity of optimized batch was compared with the 
marketed formulation of MIZ cream using cup and plate technique. 
Table 6 and Fig. 8 show the result for antimicrobial efficacy studies that 
the zone of inhibition of optimized batch was found to be almost similar 
to that of marketed formulation. Mundhey et al. found 38 mm and 
33 mm zone of inhibition for the optimized and marketed formulations 
of MTZ gel, respectively.
Fig. 4: Differential scanning calorimetry study of physical mixture 
of drug and polymer (poly-ε-caprolactone)
Fig. 5: Scanning electron microscopy of metronidazole 
microsphere
Fig. 6: Drug release study of metronidazole microsphere
Table 3: Mean particle size, partition coefficient, saturation solubility, and percentage drug entrapment efficiency of microsphere
Formulation Mean particle size (µm) Partition co efficient Saturation solubility (mg/ml) Percentage drug entrapment 
efficiency
F1 10.25±3.45 0.78 0.2 58.54±1.18
F2 19.78±1.24 1.34 0.45 63.32±2.1
F3 28.45±2.6 0.05 0.76 52.23±0.97
F4 12.96±1.4 0.12 1.5 72.62±3.66
F5 19.34±3.2 1.28 1.6 69.12±3.5
F6 20.56±3.2 0.67 0.43 56.40±1.1
F7 35.56±4.2 0.89 0.87 50.24±0.98
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Table 5: Spreadability, bioadhesive strength, and gel strength of microspheres-loaded gel
Gel code pH Gel strength (sec) Bioadhesive strength (gm) Spread ability (g.cm/sec) Drug content (%)
G1 4.09 45 5.7±1.2 3.5 62.30±0.02
G2 4.86 52 7.2±2.4 4.4 64.68±0.12
G3 3.93 42 3.5±2.3 5.2 61.39±1.2
G4 4.04 38 15.6±4.3 5.5 58.90±0.043
G5 4.02 35 6.5±1.2 4.6 70.34±1.2
G6 4.88 32 5.9±3.2 4.2 69.38±1.3
Table 6: Antimicrobial efficacy study
Fungal 
species





C. albicans (CP) 43 mm 47 mm
C. albicans: Candida albicans
Fig. 7: In vitro release profile of metronidazole from microspheres 
and microspheres-loaded gel
characteristics. The mucoadhesive gel formulation that consisted of 
drug-loaded PCL microspheres showed sustained release of >10 hrs, 
indicating their suitability for the sustained delivery of the drug. The 
observed bioadhesive strength suggests enhanced retention of the 
applied gel in the vaginal sites that is helpful in sustained release as 
well as for effective drug absorption.
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